Patents by Inventor John R. Woodward

John R. Woodward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11941119
    Abstract: Particular embodiments described herein provide for an electronic device that can be configured to allow for the mitigation of ransomware. For example, the system can determine that an application begins to execute, determine that the application attempts to modify a file, determine a file type for the file, and create a security event if the application is not authorized to modify the file type. In another example, the system determines an entropy value between the file and the attempted modification of the file, and create a security event if the entropy value satisfies a threshold or determine a system entropy value that includes a rate at which other files on the system are being modified by the application, and create a security event if the system entropy value satisfies a threshold.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: March 26, 2024
    Assignee: McAfee, LLC
    Inventors: Craig D. Schmugar, Cedric Cochin, Andrew Furtak, Adam James Carrivick, Yury Bulygin, John J. Loucaides, Oleksander Bazhaniuk, Christiaan Beek, Carl D. Woodward, Ronald Gallella, Gregory Michael Heitzmann, Joel R. Spurlock
  • Patent number: 11918864
    Abstract: Embodiments of putter-type golf club head comprising a striking surface capable of achieving consistent ball speeds across the striking surface to account for various ball impact locations are described herein. The striking surface has at least two materials that differ in concentration away from the geometric center of the striking surface to provide this consistency. Consistent (or uniform) ball speed is achieved throughout the striking surface as the portion of the golf ball that contacts the striking surface interacts with at least two materials having a differing material characteristic.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: March 5, 2024
    Assignee: Karsten Manufacturing Corporation
    Inventors: Alex G. Woodward, Matthew T. Schier, Murphy R. Alexander, Anthony D. Serrano, James D. Willmott, Erik M. Henrikson, David A. Higdon, Cole D. Brubaker, John A. Solheim
  • Publication number: 20110201579
    Abstract: A method is described herein for improving the overall health of a patient by providing subcutaneous pellets containing pregnenolone to at least one part of the body of the patient. In another embodiment, pregnenolone is mixed with DHEA into a cream and the resulting pregnenolone/DHEA cream is applied to at least one part of a body.
    Type: Application
    Filed: August 13, 2010
    Publication date: August 18, 2011
    Inventor: John R. Woodward
  • Patent number: 7967963
    Abstract: A wastewater analysis sensor cartridge (10) according to the invention is intended to be used only once. It has a liquid-tight housing (20), which contains at least one electrochemical sensor element (30, 32) and at least one reference element (56). Furthermore, the housing (20) contains a sensor element electrolyte tank (40,42) and a reference element electrolyte tank (44). The ion-sensitive membranes (31, 33) of the sensor elements (30, 32) and the housing (20) consist of plastic.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: June 28, 2011
    Assignee: Hach Lange GmbH
    Inventors: Rolf Uthemann, Andreas Golitz, John R. Woodward
  • Publication number: 20090325921
    Abstract: A method is described herein for improving the overall health of a patient by providing a topical DHEA cream and applying the topical DHEA cream to at least one part of a body. In another embodiment, the topical DHEA cream is mixed with a moisturizing lotion and the resulting DHEA/lotion mixture is applied to at least one part of a body. In yet another embodiment, the topical DHEA cream is mixed with a sulfate lotion and the resulting DHEA/sulfate lotion combination is applied to at least one part of a body.
    Type: Application
    Filed: June 23, 2009
    Publication date: December 31, 2009
    Inventor: John R. Woodward
  • Patent number: 7507703
    Abstract: A method of cancer screening comprising the steps of administering the Blood CA 27,29 testing procedure; if the result is positive administering a mammogram; if the result is positive administering a needle biopsy; if the result is positive administering a PET scan; if the result is positive administering a blood tumor cell count. If all of the foregoing steps are positive, the cancer is treated by applying imiquimod transdermally to rotating sites, preferably by mixing ALDARA™ (imiquimod) 5% cream with an equal amount of H base cream™; administering a vaccine that induces production of tumor necrosis factor, preferably the BCG vaccine; and orally administering VALTREX™ valacyclovir twice daily. The foregoing treatment method is also effective in treating Type I diabetes, MS, and other epidermal cancers.
    Type: Grant
    Filed: September 21, 2006
    Date of Patent: March 24, 2009
    Inventor: John R. Woodward
  • Publication number: 20080264788
    Abstract: A wastewater analysis sensor cartridge (10) according to the invention is intended to be used only once. It has a liquid-tight housing (20), which contains at least one electrochemical sensor element (30, 32) and at least one reference element (56). Furthermore, the housing (20) contains a sensor element electrolyte tank (40,42) and a reference element electrolyte tank (44). The ion-sensitive membranes (31, 33) of the sensor elements (30, 32) and the housing (20) consist of plastic.
    Type: Application
    Filed: March 30, 2006
    Publication date: October 30, 2008
    Applicant: HACH LANGE GMBH
    Inventors: Rolf Uthemann, Andreas Golitz, John R. Woodward
  • Publication number: 20080193482
    Abstract: A method of cancer screening comprising the steps of administering the Blood CA 27,29 testing procedure; if the result is positive administering a mammogram; if the result is positive administering a needle biopsy; if the result is positive administering a PET scan; if the result is positive administering a blood tumor cell count. If all of the foregoing steps are positive, the cancer is treated by selecting one or more treatments from a group of provided treatment according to the patient's body and condition. A method of treating auto-immune diseases comprises selecting one or more treatments from another group of provided treatments, the one or more treatments selected and administered according to the patient's body and condition.
    Type: Application
    Filed: April 9, 2008
    Publication date: August 14, 2008
    Inventor: John R. Woodward
  • Publication number: 20080119445
    Abstract: A method of sexual enhancement in women includes the steps of identifying a woman requesting sexual enhancement, assuring that the woman's blood includes estradiol within a first predetermined range and testosterone within a second predetermined range, and thereafter administrating a drug selected from the group consisting of vardenafil hydrochloride and tadalafil prior to sexual activity. The selected drug may be loaded into a starch strip which is then applied to the woman's tongue. Sexual enhancement in women can also be achieved by transdermal or subcutaneous application of the hormone DHEA.
    Type: Application
    Filed: December 17, 2007
    Publication date: May 22, 2008
    Inventor: John R. Woodward
  • Patent number: 7125836
    Abstract: A method of cancer screening comprising the steps of administering the Blood CA 27,29 testing procedure; if the result is positive administering a mammogram; if the result is positive administering a needle biopsy; if the result is positive administering a PET scan; if the result is positive administering a blood tumor cell count. If all of the foregoing steps are positive, the cancer is treated by applying imiquimod transdermally to rotating sites, preferably by mixing ALDARA (TM) (imiquimod) 5% cream with an equal amount of H base cream (TM); administering a vaccine that induces production of tumor necrosis factor, preferably the BCG vaccine; and orally administering Valtrex (TM) (valacyclovir) twice daily. The foregoing treatment method is also effective in treating Type I diabetes, MS, and other epidermal cancers.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: October 24, 2006
    Assignee: Les Medecins L.P.
    Inventor: John R. Woodward
  • Patent number: 6844934
    Abstract: An apparatus for measuring tubidity of a liquid has a tubular lens of transparent material with an aperture for receiving the liquid. First and second first light emitters are positioned adjacent the tubular lens to produce two beams of light each diverging at a predefined angle and impinging the tubular lens. The tubular lens refracts the diverging beams of light from the two light emitters into separate collimated beams within the aperture. A first light detector positioned adjacent the tubular lens diametrically opposite to the first light emitter and a second light detector positioned diametrically opposite to the first light emitter and a second light detector positioned diametrically opposite to the second light emitter. Each light detector produces a signal indicating an intensity of light received from within the tubular lens and the signals are process to derive a turbidity measurement.
    Type: Grant
    Filed: May 21, 2002
    Date of Patent: January 18, 2005
    Assignee: Hach Company
    Inventors: Gregory S. Retzlaff, John R. Woodward, Terry L. Dickey, Karl King
  • Publication number: 20040145742
    Abstract: An apparatus for measuring tubidity of a liquid has a tubular lens of transparent material with an aperture for receiving the liquid. First and second first light emitters are positioned adjacent the tubular lens to produce two beams of light each diverging at a predefined angle and impinging the tubular lens. The tubular lens refracts the diverging beams of light from the two light emitters into separate collimated beams within the aperture. A first light detector positioned adjacent the tubular lens diametrically opposite to the first light emitter and a second light detector positioned diametrically opposite to the first light emitter and a second light detector positioned diametrically opposite to the second light emitter. Each light detector produces a signal indicating an intensity of light received from within the tubular lens and the signals are process to derive a turbidity measurement.
    Type: Application
    Filed: November 20, 2003
    Publication date: July 29, 2004
    Inventors: Gregory S Retzlaff, John R Woodward, Terry L Dickey, Karl King
  • Patent number: 5527509
    Abstract: A colorimetric enzymic analytical test element comprises a support and a plurality of reaction zones incorporating a dried enzyme composition, dyestuff and reagent adapted to provide a substantial dosage independent colorimetric display when the concentration of an analyte applied to the elements exceeds a predetermined value.
    Type: Grant
    Filed: September 30, 1992
    Date of Patent: June 18, 1996
    Assignee: Cranfield Biotechnology Ltd.
    Inventors: Timothy D. Gibson, John R. Woodward, Irving J. Higgins, William J. Aston, David A. Griffiths
  • Patent number: 5240843
    Abstract: A method of stabilising enzymes or other proteins against denaturation or drying comprises mixing the protein with a cyclic polyol and a cationic polyelectrolyte.
    Type: Grant
    Filed: June 27, 1991
    Date of Patent: August 31, 1993
    Assignee: Cranfield Biotechnology Ltd.
    Inventors: Timothy D. Gibson, John R. Woodward
  • Patent number: 4421668
    Abstract: A liquid bleach composition comprises a hydrogen peroxide precursor which includes as an enzyme an alcohol oxidase and as a substrate for the enzyme the corresponding alcohol, the enzyme and the substrate being incapable of substantial interaction in the composition. The composition contains less than 1 unit of catalase for every 2 units of the alcohol oxidase so that peroxide formation, when the composition is diluted with 100 times its volume of water to trigger the interaction of the enzyme and its substrate, it not substantially impaired. The diluted composition has a pH value of from 7.5 to 11. Preferably, the composition also comprises detergent active compound.
    Type: Grant
    Filed: June 16, 1982
    Date of Patent: December 20, 1983
    Assignee: Lever Brothers Company
    Inventors: Roger B. Cox, David C. Steer, John R. Woodward